Navigation Links
Cepheid to Present at Cowen and Company's 28th Annual Healthcare Conference
Date:3/10/2008

SUNNYVALE, Calif., March 10 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) will present at Cowen and Company's 28th Annual Healthcare Conference on March 18 at 10:15 a.m. ET at The Boston Marriott Copley Place in Boston. John L. Bishop, Chief Executive Officer, will provide a corporate overview.

The webcast, along with accompanying presentation slides, may be accessed on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentation will be available for 90 days.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080129/LATU101LOGO)


'/>"/>
SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Reports Fourth Quarter and Full Year 2007 Results
2. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
3. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
4. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
5. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
6. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
7. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
8. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
9. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
10. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
11. AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet Products ... specific properties for use in harsh environments inside or outside of the human ... three metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or ...
(Date:1/7/2020)... ... January 07, 2020 , ... ... services, today announced the launch of its VivopureX™ recombinant mouse antibodies for in ... originally obtained from rats or hamsters, which Absolute Antibody has engineered into mouse-anti-mouse ...
(Date:1/7/2020)... Mass. (PRWEB) , ... January 06, 2020 , ... ... for a Digital World at The Fletcher School at Tufts University, is pleased ... Sloan Foundation. The grant will be administered by Tufts University, and will help ...
(Date:1/7/2020)... ... January 06, 2020 , ... ... second cohort of emerging biosciences ventures invited to participate in the annual program. ... develop fundable business plans and a professional network. All startups will receive an ...
Breaking Biology Technology:
(Date:12/4/2019)... ... December 03, 2019 , ... Genedata, the leading provider of ... clinical-stage immuno-oncology company developing therapies to fight cancer, has chosen Genedata Biologics ... the platform to support immunotherapy and vaccine pipeline programs across their global organization. ...
(Date:11/27/2019)... (PRWEB) , ... November 25, 2019 , ... Though the ... for the more than 55 million travelers expected to hit the roads and the ... application worth it’s weight in truffle oil will offer a simple design, mouth-watering pictures ...
(Date:11/20/2019)... ... , ... BioInformatics Inc., part of Science and Medicine Group, the leading research ... the Life Science Industry Awards for the most innovative new products in 2019. , ... Most Innovative New Product – Cell Biology, Fluidigm (Gold ...
Breaking Biology News(10 mins):